Development and Characterization of Cefoxitin Loaded D,L-PLA Nanoparticles

Nanoparticles containing cefoxitin (CEF) made of D,L-PLA (PLA) were designed by a multiple emulsion/solvent evaporation method. The particles were extensively evaluated in relation to morphology, encapsulation efficiency, drug-polymer interactions as well as in vitro drug release kinetics. Nanoparti...

Full description

Saved in:
Bibliographic Details
Main Authors: S.R.P. Machado (Author), R.C. Evangelista (Author)
Format: Book
Published: São Paulo State University (UNESP), 2010-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_24c903e50e4b48e89024f028b6548fe1
042 |a dc 
100 1 0 |a S.R.P. Machado  |e author 
700 1 0 |a R.C. Evangelista  |e author 
245 0 0 |a Development and Characterization of Cefoxitin Loaded D,L-PLA Nanoparticles 
260 |b São Paulo State University (UNESP),   |c 2010-09-01T00:00:00Z. 
500 |a 1808-4532 
500 |a 2179-443X 
520 |a Nanoparticles containing cefoxitin (CEF) made of D,L-PLA (PLA) were designed by a multiple emulsion/solvent evaporation method. The particles were extensively evaluated in relation to morphology, encapsulation efficiency, drug-polymer interactions as well as in vitro drug release kinetics. Nanoparticles were spherical in shape and isolated, with a mean diameter of about 600 nm. The thermal behaviour (DSC) of CEF-containing nanoparticles suggested that the drug was dispersed at a molecular level within the system. The drug encapsulation efficiency in the system for a CEF concentration of 30 mg/mL was 5.5%, as assessed after the drug extraction, by a validated HPLC method. This low encapsulation efficiency is understandable, since CEF is highly hydrophilic. The in vitro assays showed a strong sustained drug release profile from the nanoparticles with kinetics following pure Fickian diffusion. 
546 |a EN 
690 |a nanoparticles. controlled release. d,l-pla. cefoxitin. in vitro release. 
690 |a Pharmaceutical industry 
690 |a HD9665-9675 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Revista de Ciências Farmacêuticas Básica e Aplicada, Vol 31, Iss 3 (2010) 
787 0 |n http://rcfba.fcfar.unesp.br/index.php/ojs/article/view/365 
787 0 |n https://doaj.org/toc/1808-4532 
787 0 |n https://doaj.org/toc/2179-443X 
856 4 1 |u https://doaj.org/article/24c903e50e4b48e89024f028b6548fe1  |z Connect to this object online.